These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19489066)

  • 21. Effects of botulinum toxin A on the contractile function of dog prostate.
    Lin AT; Yang AH; Chen KK
    Eur Urol; 2007 Aug; 52(2):582-9. PubMed ID: 17386969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fresh and stored botulinum toxin a on muscle and nerve ultrastructure: an electron microscopic study.
    Elmas C; Ayhan S; Tuncer S; Erdogan D; Calguner E; Basterzï Y; Gozil R; Bahcelioglu M
    Ann Plast Surg; 2007 Sep; 59(3):316-22. PubMed ID: 17721223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UV-B irradiation attenuates dermal effects of botulinum toxin A: a randomized, double-blind, placebo-controlled study.
    Sycha T; Kotzailias N; Kranz G; Trautinger F; Schnider P; Auff E
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S92-6. PubMed ID: 17241421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Texture analysis of magnetic resonance images of rat muscles during atrophy and regeneration.
    Mahmoud-Ghoneim D; Cherel Y; Lemaire L; de Certaines JD; Maniere A
    Magn Reson Imaging; 2006 Feb; 24(2):167-71. PubMed ID: 16455405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoring balance in focal limb dystonia with botulinum toxin.
    Sheean G
    Disabil Rehabil; 2007 Dec; 29(23):1778-88. PubMed ID: 18033603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: a pilot study.
    Terre R; Valles M; Panades A; Mearin F
    Scand J Gastroenterol; 2008; 43(11):1296-303. PubMed ID: 18649151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.
    Tugnoli V; Capone JG; Eleopra R; Quatrale R; Sensi M; Gastaldo E; Tola MR; Geppetti P
    Pain; 2007 Jul; 130(1-2):76-83. PubMed ID: 17194546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Split-screen video demonstration of sonography-guided muscle identification and injection of botulinum toxin.
    Fietzek UM; Schroeder AS; Wissel J; Heinen F; Berweck S
    Mov Disord; 2010 Oct; 25(13):2225-8. PubMed ID: 20721881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use.
    Parsa AA; Lye KD; Parsa FD
    Aesthetic Plast Surg; 2007; 31(2):188-91; discussion 192-3. PubMed ID: 17122996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
    Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
    Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vivo rat muscle force model is a reliable and clinically relevant test of consistency among botulinum toxin preparations.
    Pickett A; O'Keeffe R; Judge A; Dodd S
    Toxicon; 2008 Sep; 52(3):455-64. PubMed ID: 18639570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin (BoNT) and back pain.
    Porta M; Maggioni G
    J Neurol; 2004 Feb; 251 Suppl 1():I15-8. PubMed ID: 14991338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Botulinum toxin for the treatment of pain syndromes].
    Ferreira JJ; Couto M; Costa J; Coelho M; Rosa MM; Sampaio C
    Acta Reumatol Port; 2006; 31(1):49-62. PubMed ID: 17058384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between neurectomy and botulinum toxin A injection for denervated skeletal muscle.
    Tsai FC; Hsieh MS; Chou CM
    J Neurotrauma; 2010 Aug; 27(8):1509-16. PubMed ID: 20528164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STIR MRI to direct muscle biopsy in suspected idiopathic inflammatory myopathy.
    Connor A; Stebbings S; Anne Hung N; Hammond-Tooke G; Meikle G; Highton J
    J Clin Rheumatol; 2007 Dec; 13(6):341-5. PubMed ID: 18176145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of botulinum toxin type A injection on compound muscle action potential in an in vivo rat model.
    Cichon JV; McCaffrey TV; Litchy WJ; Knops JL
    Laryngoscope; 1995 Feb; 105(2):144-8. PubMed ID: 8544593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B; Rzany BJ; Grover R
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A.
    Sloop RR; Escutin RO; Matus JA; Cole BA; Peterson GW
    Neurology; 1996 May; 46(5):1382-6. PubMed ID: 8628486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion.
    Lim EC; Seet RC
    Acta Neurol Scand; 2008 Feb; 117(2):73-84. PubMed ID: 17850405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of botulinum neurotoxin for spasticity].
    Mukai Y; Kaji R
    Brain Nerve; 2008 Dec; 60(12):1421-6. PubMed ID: 19110753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.